Blueprint Medicines (BPMC) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
https://www.zacks.com/stock/news/2223454/blueprint-medicines-bpmc-expected-to-beat-earnings-estimates-what-to-know-ahead-of-q4-release?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2223454
Feb 08, 2024 - Blueprint Medicines (BPMC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
0
Drug, Biotech Stock Q4 Earnings Due on Feb 15: ALNY, BPMC & More
https://www.zacks.com/stock/news/2226283/drug-biotech-stock-q4-earnings-due-on-feb-15-alny-bpmc-more?cid=CS-ZC-FT-analyst_blog|earnings_preview_-_esp-2226283
Feb 14, 2024 - Let's look at five biotech/drug companies, ALNY, BPMC, AGIO, CORT and RARE, slated to release quarterly results on Feb 15.
0
Here's What Key Metrics Tell Us About Blueprint Medicines (BPMC) Q4 Earnings
https://www.zacks.com/stock/news/2227594/here-s-what-key-metrics-tell-us-about-blueprint-medicines-bpmc-q4-earnings?cid=CS-ZC-FT-fundamental_analysis|nfm-2227594
Feb 16, 2024 - While the top- and bottom-line numbers for Blueprint Medicines (BPMC) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
0
Pages: 1
Page 1